MIRD Pamphlet No. 34, Part 2: Benchmarking of MIRDct Software for CT Organ Dose Estimation [0.03%]
MIRD小册子第34部分第2篇：MIRDct软件的基准测试以进行CT器官剂量估算
Gunjan Kayal,Juan Camilo Ocampo Ramos,Laura E Dinwiddie et al.
Gunjan Kayal et al.
Accurate estimation of organ and effective doses in CT imaging is essential for risk assessment, protocol optimization, and personalized care in diagnostic radiology and nuclear medicine. We systematically benchmarked MIRDct, a freely avail...
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial [0.03%]
高危儿童霍奇金淋巴瘤患者基线及中期治疗正电子发射断层扫描特征的预后评估：AHOD1331方案的回顾性分析
Xin Tie,Changhee Lee,Scott B Perlman et al.
Xin Tie et al.
This study aimed to evaluate the prognostic value of conventional and advanced PET metrics for predicting progression-free survival in high-risk pediatric Hodgkin lymphoma (HL), using data from the Children's Oncology Group AHOD1331 trial. ...
Pediatric Reference Ranges for Glomerular Filtration Rate Determined by a Single Injection of 99mTc-DTPA [0.03%]
一次性注射99mTc-DTPA测定肾小球滤过率的儿童参考范围
Katherine A Zukotynski,Frederick D Grant,Leanne Du et al.
Katherine A Zukotynski et al.
Determination of glomerular filtration rate (GFR) with 99mTc-labeled diethylenetriaminepentaacetic acid (99mTc-DTPA) is a validated method to assess renal function, but there are no well-established pediatric reference ranges for GFR. The a...
Functional Renal Assessment via Dynamic LAFOV 18F-FDG PET/CT in a Patient with Recurrent Extranodal Marginal-Zone Lymphoma [0.03%]
复发性结外边缘区淋巴瘤患者的功能性肾动态LAFOV 18F-FDG PET/CT评估研究
Jonathan Kuten,Bradley J Beattie,Stephanie Chahwan et al.
Jonathan Kuten et al.
We report the case of a 72-y-old man with recurrent extranodal marginal-zone B-cell lymphoma who underwent dynamic long-axial-field-of-view 18F-FDG PET/CT. In addition to detecting extensive recurrent disease, a review of a maximum-intensit...
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort [0.03%]
寡转移去势抵抗性前列腺癌影像学检查方式和定向治疗预后的相关性：来自PRECISE-MDT队列的更新分析结果
Matteo Bauckneht,Liliana Belgioia,Domenico Albano et al.
Matteo Bauckneht et al.
It is unclear whether the imaging modality used to guide metastasis-directed therapy (MDT) influences outcomes in oligometastatic castration-resistant prostate cancer (omCRPC). Methods: We performed an updated analysis of the PRECISE-MDT co...
Nonsteroidal 18F-Labeled PET Tracer for Imaging Androgen Receptors [0.03%]
非甾体类氟-18标记的PET示踪剂用于雄激素受体显像
Vilma I J Jallinoja,Joo Sun Mun,Alexandra Campanella et al.
Vilma I J Jallinoja et al.
Androgen receptor (AR) signaling is the key driver of prostate cancer. Thus, standard-of-care treatments focus on androgen-deprivation therapy followed by AR signaling inhibitors. Even when initially responsive, patients eventually develop ...
Somatostatin Receptor Expression on [68Ga]Ga-DOTATATE PET Among Patients with Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas: A Prospective Study [0.03%]
[68Ga]Ga-DOTATATE PET在分化差的肺外神经内分泌癌患者中的生长抑素受体表达：一项前瞻性研究
Jonathan R Strosberg,Taymeyah Al-Toubah,Mintallah Haider et al.
Jonathan R Strosberg et al.
Limited data are available regarding somatostatin receptor (SSTR) expression in poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). Some retrospective series have reported strong SSTR expression in up to 40% of patients wit...
Total-Body Dynamic PET/CT Imaging of Proton-Induced Activity and Biologic Washout After Proton Therapy [0.03%]
质子治疗后的总身体动态PET/CT显像及生物排空研究
Hongmei Tang,Shuang Song,Fei Liu et al.
Hongmei Tang et al.
Off-line PET imaging after proton therapy is limited by transport delay and by the sensitivity and short axial field of view of conventional scanners, which hinder imaging at ultralow activity and characterization of whole-body biologic was...
Treatment of Human Glioblastoma Multiforme in NRG Mice by Convection-Enhanced Delivery of EGFR-Targeted or Nontargeted Auger Electron-Emitting 197gHg-Labeled Gold Nanoparticles [0.03%]
用大范围效应电子发射的197Hg标记金纳米颗粒对NRG小鼠的人胶质母细胞瘤的治疗
Madeline K Brown,Zhongli Cai,Yumeela Ganga-Sah et al.
Madeline K Brown et al.
The effectiveness and safety of Auger electron (AE)-emitting epidermal growth factor receptor (EGFR)-targeted panitumumab-197gHg-gold nanoparticles (AuNPs) or nontargeted 197gHg-AuNPs for treating glioblastoma multiforme (GBM) were studied ...
Concetta Luisi,Luca De Palma,Cristina Campi et al.
Concetta Luisi et al.
We hypothesized that [18F]FDG PET/MRI would improve presurgical lesion detection compared with MRI alone in pediatric patients with focal epilepsy. We analyzed surgical outcomes and the presurgical evaluation pipeline. Methods: We included ...